Literature DB >> 20835693

[The role of erythropoietin in improvement of wound healing].

H Sorg1, J W Kuhbier, B Menger, K Reimers, Y Harder, P M Vogt.   

Abstract

Pleiotropic substances are characterized by their versatile and complex range of actions which makes them potential new active agents for the therapy of wounds. Besides its known effect to increase red blood cell production, the glycoprotein hormone erythropoietin (EPO) has been found to demonstrate a tissue protective effect in several other organs. The administration of EPO during skin wound healing is most likely essentially based on its cytopotective, proangiogenic, antiapoptotic and antiinflammatory effects. Herein EPO stimulates a coordinated interaction of different types of cells at a low or only a single dose. This review article aims to present the advantages and disadvantages of EPO administration in different experimental models to study the healing and regeneration processes of the skin and discusses possible clinical applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20835693     DOI: 10.1007/s00104-010-1978-3

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  28 in total

1.  A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent.

Authors:  R Savino; G Ciliberto
Journal:  Cell Death Differ       Date:  2004-07       Impact factor: 15.828

2.  Interferon-alfa- and erythropoetin-associated cerebral vasoconstriction.

Authors:  N Gaillard; A Mania; H Brunel; F Blanc; C Arquizan
Journal:  Cephalalgia       Date:  2009-06-01       Impact factor: 6.292

3.  Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.

Authors:  D Ribatti; M Presta; A Vacca; R Ria; R Giuliani; P Dell'Era; B Nico; L Roncali; F Dammacco
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

4.  In vivo evidence that erythropoietin protects neurons from ischemic damage.

Authors:  M Sakanaka; T C Wen; S Matsuda; S Masuda; E Morishita; M Nagao; R Sasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

5.  Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse.

Authors:  Mariarosaria Galeano; Domenica Altavilla; Domenico Cucinotta; Giuseppina T Russo; Margherita Calò; Alessandra Bitto; Herbert Marini; Rolando Marini; Elena B Adamo; Paolo Seminara; Letteria Minutoli; Valerio Torre; Francesco Squadrito
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

Review 6.  Erythropoietin as an antiapoptotic, tissue-protective cytokine.

Authors:  P Ghezzi; M Brines
Journal:  Cell Death Differ       Date:  2004-07       Impact factor: 15.828

7.  A novel role for erythropoietin during fibrin-induced wound-healing response.

Authors:  Zishan A Haroon; Khalid Amin; Xiaohong Jiang; Murat O Arcasoy
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 8.  Use of erythropoiesis-stimulating agents in patients with anemia of chronic kidney disease: overcoming the pharmacological and pharmacoeconomic limitations of existing therapies.

Authors:  Jay B Wish; Daniel W Coyne
Journal:  Mayo Clin Proc       Date:  2007-11       Impact factor: 7.616

9.  Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice.

Authors:  Thomas Quaschning; Frank Ruschitzka; Thomas Stallmach; Sidney Shaw; Henning Morawietz; Winfried Goettsch; Matthias Hermann; Torsten Slowinski; Franz Theuring; Berthold Hocher; Thomas F Lüscher; Max Gassmann
Journal:  FASEB J       Date:  2002-12-18       Impact factor: 5.191

10.  Risk factors for leukemic transformation in patients with primary myelofibrosis.

Authors:  Jocelin Huang; Chin-Yang Li; Ruben A Mesa; Wentling Wu; Curtis A Hanson; Animesh Pardanani; Ayalew Tefferi
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.